We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+3.2%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$629B
AUM Growth
+$13B
Cap. Flow
+$935M
Cap. Flow %
0.15%
Top 10 Hldgs %
19.19%
Holding
2,649
New
91
Increased
1,526
Reduced
842
Closed
97

Top Buys

Rank Stock Value
1
TXN icon
Texas Instruments
TXN
+$2.29B
2
META icon
Meta Platforms (Facebook)
META
+$1.81B
3
AVGO icon
Broadcom
AVGO
+$1.61B
4
TSLA icon
Tesla
TSLA
+$1.59B
5
SRE icon
Sempra
SRE
+$1.26B

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$6.14B
2
AMZN icon
Amazon
AMZN
+$2.54B
3
AET
Aetna Inc
AET
+$1.44B
4
BIIB icon
Biogen
BIIB
+$1.4B
5
NFLX icon
Netflix
NFLX
+$1.12B

Sector Composition

Rank Sector Weight
1 Technology 16.61%
2 Healthcare 16.14%
3 Financials 15.97%
4 Consumer Discretionary 14.71%
5 Industrials 9.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BLFS icon
2451
BioLife Solutions
BLFS
$1.71B
$144K ﹤0.01%
28,200
+3,400
+14% +$18.4K
GROW icon
2452
US Global Investors
GROW
$38.7M
$143K ﹤0.01%
56,500
– –
PTGX icon
2453
Protagonist Therapeutics
PTGX
$9.84B
$142K ﹤0.01%
16,543
+6,722
+68% +$127K
VSTM icon
2454
Verastem
VSTM
$629M
$141K ﹤0.01%
3,942
-5,108
-56% -$198K
SELF
2455
Global Self Storage
SELF
$58.6M
$139K ﹤0.01%
31,400
– –
SWBI icon
2456
Smith & Wesson
SWBI
$636M
$139K ﹤0.01%
+17,465
New +$147K
KGC icon
2457
Kinross Gold
KGC
$32.6B
$138K ﹤0.01%
35,000
– –
WKHS icon
2458
Workhorse Group
WKHS
$33.7M
$137K ﹤0.01%
17
+8
+89% +$69.9K
UPL
2459
DELISTED
Ultra Petroleum Corp. Common Stock
UPL
$137K ﹤0.01%
32,828
+380
+1% +$2.22K
FIT
2460
DELISTED
Fitbit, Inc. Class A common stock
FIT
$136K ﹤0.01%
26,668
+378
+1% +$2.01K
IMNN icon
2461
Imunon
IMNN
$6.77M
$135K ﹤0.01%
308
– –
IVAC
2462
DELISTED
Intevac Inc
IVAC
$135K ﹤0.01%
19,594
+39
+0.2% +$257
PRTK
2463
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$133K ﹤0.01%
+10,212
New +$152K
FTR
2464
DELISTED
Frontier Communications Corp.
FTR
$132K ﹤0.01%
17,847
+153
+0.9% +$1.19K
FMSA
2465
DELISTED
Fairmount Santrol Holdings Inc.
FMSA
$130K ﹤0.01%
30,537
+302
+1% +$1.52K
ACTG icon
2466
Acacia Research
ACTG
$455M
$128K ﹤0.01%
36,535
+96
+0.3% +$352
TBHC
2467
DELISTED
The Brand House Collective
TBHC
$127K ﹤0.01%
13,070
+30
+0.2% +$315
QMCO icon
2468
Quantum Corp
QMCO
$864M
$127K ﹤0.01%
1,742
+3
+0.2% +$292
PZN
2469
DELISTED
Pzena Investment Management, Inc. Class A
PZN
$127K ﹤0.01%
11,373
+33
+0.3% +$374
WTI icon
2470
W&T Offshore
WTI
$555M
$126K ﹤0.01%
28,546
+183
+0.6% +$775
ASXC
2471
DELISTED
Asensus Surgical, Inc.
ASXC
$126K ﹤0.01%
5,708
+46
+0.8% +$1.05K
LPTH icon
2472
Lightpath Technologies
LPTH
$862M
$124K ﹤0.01%
56,300
+1,900
+3% +$4.36K
RPXC
2473
DELISTED
RPX Corporation
RPXC
$124K ﹤0.01%
11,627
+90
+0.8% +$1.1K
OMER icon
2474
Omeros
OMER
$992M
$123K ﹤0.01%
11,002
+89
+0.8% +$1.25K
INOV
2475
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
$123K ﹤0.01%
11,601
+125
+1% +$1.57K
97 98
99
100 101

Similar funds

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

T. Rowe Price Associates's Q1 2018 Portfolio in Review

As of Q1 2018, T. Rowe Price Associates held 2,649 positions worth $629B, up 2.1% from $616B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

T. Rowe Price Associates's Q1 2018 filing shows 91 new, 1,526 increased, 842 reduced and 97 closed positions. Its largest new stake was Sempra Energy 6% Mandatory Convertible Preferred Stock, Series A: 6,723,426 shares worth $688M. The largest sale was Apple, an estimated $6.14B.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q1 2018 buy was Sempra Energy 6% Mandatory Convertible Preferred Stock, Series A: 6,723,426 shares worth $688M.
  • T. Rowe Price Associates added most to Texas Instruments in Q1 2018, an estimated $2.29B increase.
  • T. Rowe Price Associates's biggest Q1 2018 reduction was Apple, cutting an estimated $6.14B.
  • T. Rowe Price Associates fully exited Liberty Interactive Corporation Series A Liberty Ventures in Q1 2018, selling an estimated $395M.
  • T. Rowe Price Associates's ten largest holdings make up 19% of its $629B portfolio in Q1 2018.
  • T. Rowe Price Associates opened 91 new positions and closed 97 in Q1 2018.
  • T. Rowe Price Associates's portfolio value rose 2.1% quarter-over-quarter to $629B.

Based on T. Rowe Price Associates's 13F filing for Q1 2018, filed 14 May 2018.